2025 Saudi Arabia Molecular Diagnostics Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides molecular diagnostics market shares.
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Labcorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Labcorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
2021 Beckman Coulter US, Europe, Japan - Diagnostics Market Shares and Competitive Position by Product and Country - Performance, Capabilities, Goals and Strategies
US$ 1,850.00
December 2020
111 pages
Colombia Hemostasis Market Database--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests
US$ 1,500.00
March 2024
-
Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan-Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 28,500.00
June 2019
1398 pages
2016-2020 Drugs of Abuse Testing in the US Hospitals, Commercial Laboratories, Emergency Rooms and Ambulatory Care Centers
US$ 3,600.00
March 2016
278 pages
2016-2020 Tumor Marker Testing Market: Strategic Assessments of Current and Emerging Competitors
US$ 2,000.00
March 2016
80 pages
